Billy Evans, a partner of the founder of Theranos, Elizabeth Holmes, is working on a new startup that seeks to offer “human health optimization” through blood tests, According to the New York Times.
According to reports, the Times spoke with two investors launched in the startup, called Haemanthus, and also saw some of Haemathus’s marketing materials.
In these materials, the company says that it has developed a machine that uses lasers to analyze samples of blood, saliva and urine to detect cancer and infections. According to reports, he plans to start with the health of pets before expanding to humans, and seeks to raise more than $ 50 million.
The tone resonates in Theranos, which promised to perform a variety of medical tests in small amounts of blood extracted from the punctured fingers. In 2022, Holmes (with whom Evans has two children) was sentenced to 11 years in prison However, to disappoint investors She said in a recent interview that she remains “completely committed to my dream of making available to all affordable medical care solutions for all.”
Facebook’s first investor Jim Breyer told the Times that he asked his team to invest, but declined “for many of the same reasons why we passed twice in Theranians.”